Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2006 3
2009 3
2010 5
2011 6
2012 4
2013 8
2014 14
2015 13
2016 7
2017 14
2018 17
2019 16
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 28720633

112 results
Results by year
Filters applied: . Clear all
Page 1
Factors That Influence Treatment Completion for Latent Tuberculosis Infection.
Eastment MC, McClintock AH, McKinney CM, Narita M, Molnar A. Eastment MC, et al. J Am Board Fam Med. 2017 Jul-Aug;30(4):520-527. doi: 10.3122/jabfm.2017.04.170070. J Am Board Fam Med. 2017. PMID: 28720633 Free article.
Impacts of 12-dose regimen for latent tuberculosis infection: Treatment completion rate and cost-effectiveness in Taiwan.
Huang YW, Yang SF, Yeh YP, Tsao TC, Tsao SM. Huang YW, et al. Medicine (Baltimore). 2016 Aug;95(34):e4126. doi: 10.1097/MD.0000000000004126. Medicine (Baltimore). 2016. PMID: 27559940 Free PMC article.
Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.
Simkins J, Abbo LM, Camargo JF, Rosa R, Morris MI. Simkins J, et al. Transplantation. 2017 Jun;101(6):1468-1472. doi: 10.1097/TP.0000000000001329. Transplantation. 2017. PMID: 27548035
Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA. Schein YL, et al. BMC Infect Dis. 2018 Nov 19;18(1):587. doi: 10.1186/s12879-018-3468-z. BMC Infect Dis. 2018. PMID: 30453946 Free PMC article.
High Completion Rate for 12 Weekly Doses of Isoniazid and Rifapentine as Treatment for Latent Mycobacterium tuberculosis Infection in the Federal Bureau of Prisons.
Schmit KM, Lobato MN, Lang SG, Wheeler S, Kendig NE, Bur S. Schmit KM, et al. J Public Health Manag Pract. 2019 Mar/Apr;25(2):E1-E6. doi: 10.1097/PHH.0000000000000822. J Public Health Manag Pract. 2019. PMID: 30024493 Free PMC article.
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.
McClintock AH, Eastment M, McKinney CM, Pitney CL, Narita M, Park DR, Dhanireddy S, Molnar A. McClintock AH, et al. BMC Infect Dis. 2017 Feb 14;17(1):146. doi: 10.1186/s12879-017-2245-8. BMC Infect Dis. 2017. PMID: 28196479 Free PMC article.
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.
Belknap R, Holland D, Feng PJ, Millet JP, Caylà JA, Martinson NA, Wright A, Chen MP, Moro RN, Scott NA, Arevalo B, Miró JM, Villarino ME, Weiner M, Borisov AS; TB Trials Consortium iAdhere Study Team. Belknap R, et al. Ann Intern Med. 2017 Nov 21;167(10):689-697. doi: 10.7326/M17-1150. Epub 2017 Nov 7. Ann Intern Med. 2017. PMID: 29114781 Free PMC article. Clinical Trial.
Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
Doan TN, Fox GJ, Meehan MT, Scott N, Ragonnet R, Viney K, Trauer JM, McBryde ES. Doan TN, et al. J Antimicrob Chemother. 2019 Jan 1;74(1):218-227. doi: 10.1093/jac/dky403. J Antimicrob Chemother. 2019. PMID: 30295760
House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective study.
Chang AH, Polesky A, Bhatia G. Chang AH, et al. BMC Public Health. 2013 Sep 28;13:894. doi: 10.1186/1471-2458-13-894. BMC Public Health. 2013. PMID: 24073620 Free PMC article.
Completion rate of latent tuberculosis infection treatment in patients aged 65 years and older.
Noh CS, Kim HI, Choi H, Kim Y, Kim CH, Choi JH, Hyun IG, Baek MS. Noh CS, et al. Respir Med. 2019 Oct;157:52-58. doi: 10.1016/j.rmed.2019.09.004. Epub 2019 Sep 9. Respir Med. 2019. PMID: 31522030
112 results
Jump to page
Feedback